The VERTEX NEO Ultra Bench-Top Vacuum FT-IR System is a fully automated vacuum FT-IR instrument that provides high resolution ...

Using a kind of novel linker technology, the startup is developing versions of incretin and non-incretin therapies that can ...

Vertex Pharmaceuticals dominates the cystic fibrosis treatment market and recently has expanded into other therapeutic areas. The biotech predicts full-year 2025 revenue of as much as $12 billion.

SAN FRANCISCO - Bruker Corporation (NASDAQ:BRKR) has acquired AST Revolution, LLC, a developer of rapid antimicrobial susceptibility testing solutions, according to a press release statement from ...

Bruker Corporation today announced the launch of the VERTEX NEO Ultra, its most advanced and versatile benchtop vacuum Fourier-Transform Infrared (FT-IR) spectrometer. Building on the VERTEX NEO ...